Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor(-/-) mice

Endocrinology

Volumn 139, Issue 7, 1998, Pages 3127-3132

  Scrocchi, Louise A ^a   Drucker, Daniel J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; HORMONE RECEPTOR; INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0031731090     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.7.6092     Document Type: Article

References (44)

1. Mojsov S, Weir GC, Habener JF 1987 Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619
2. Kreymann B, Ghatei MA, Williams G, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304
3. Holst JJ, Orskov C, Nielsen OV, Schwartz TW 1987 Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174
4. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322
5. Ahren B, Larsson H, Holst JJ 1997 Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:473-478
6. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF 1987 Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84:3434-3438
7. Fehmann H-C, Habener JF 1992 Insulinotropic hormone glucagon-like peptide-1(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130:159-166
8. Holz GG, Kühtreiber WM, Habener JF 1993 Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365
9. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA 1996 Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36)amide in type 2 (non-insulin dependent) diabetic patients. J Clin Endocrinol Metab 81:327-332
10. Nauck MA, Wollschlager D, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Willms B 1996 Effects of subcutaneous glucagon-like peptide 1 (GLP-1[7-36 amide]) in patients with NIDDM. Diabetologia 39:1546-1553
11. Toft-Nielsen M, Madsbad S Holst JJ 1996 The effect of glucagon-like peptide 1 (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes 45:552-556
12. Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC 1996 Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1(7-36)amide in patients with NIDDM. Diabetes 45:1524-1530
13. D'Alessio DA, Vogel R, Prigeon R, Laschansky E, Koerker D, Eng J, Ensinck JW 1996 Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest 97:133-138
14. Kolligs F, Fehmann H-C, Göke R, Göke B 1995 Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19
15. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR 1995 Glucagon-like peptide 1 is a physiological incretin in rat. J Clin Invest 95:417-421
16. Drucker DJ, Asa S 1988 Glucagon gene expression in vertebrate brain. J Biol Chem 263:13475-13478
17. Han VKM, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK 1986 Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J Neurosci Res 16:97-107
18. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C 1997 Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257-270
19. Comb M, Mermod N, Hyman SE, Pearlberg, Ross ME, Goodman HM 1989 Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J 7:3793-3805
20. Uttenthal LO, Toledano A, Blazquez E 1992 Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36)amide in rat brain. Neuropeptides 21:143-146
21. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JPH, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
22. Thorens B 1992 Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide I. Proc Natl Acad Sci USA 89:8641-8645
23. Wei Y, Mojsov S 1995 Tissue-specific expression of the human receptor for glucagon-like peptide 1: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 358:219-224
24. Dillon JS, Tanizawa Y, Wheeler MB, Leng X-H, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, Boyd III AE 1993 Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. Endocrinology 133:1907-1910
25. Lankat-Buttgereit B, Goke R, Fehmann H-C, Richter G, Goke B 1994 Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung. Exp Clin Endocrinol 102:341-347
26. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide-receptor gene. Nat Med 2:1254-1258
27. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC 1993 Derivation of completely cell culture-derived mice from early passage embryonic stem cells. Proc Natl Acad Sci USA 90:8424-8428
28. Nagy A, Rossant J 1993 In: Joyner AL (ed) Production of completely ES cell-derived fetuses. Gene Targeting: A Practical Approach, Oxford University Press, Oxford, pp 147-180
29. Coleman DL, Eicher EM 1990 Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 81:424-427
30. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP 1996 Central administration of GLP-1(7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848-R856
31. Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein H, Seeley RJ 1997 Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am J Physiol 272:R726-R730
32. McMahon LR, Wellman PJ 1998 PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol 274:R23-R29
33. Flint A, Raben A, Astrup A, Holst JJ 1998 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515-520
34. Van Dijk G, Thiele TE, Donahey JCK, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ 1996 Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 271:R1096-R1100
35. Donahey JCK, Van Dijk G, Woods SC, Seeley RJ 1998 Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res 779:75-83
36. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Lui SM, Tartaglia L, Leibel RL 1996 Phenotypes of mouse diabetes and rat fatty due to mutation in the Ob (leptin) receptor. Science 271:994-996
37. Surwit RS, Petro AE, Parekh P, Collins S 1997 Low plasma leptin in response to dietary fat in diabetes-and obesity-prone mice. Diabetes 46:1516-1520
38. Erickson JC, Clegg KE, Palmiter RD 1996 Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-418
39. Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707
40. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA 1945 Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis. Cell 83:69-78
41. Ueda H, Ikegami H, Yamato E, Fu J, Fukuda M, Shen G, Kawaguchi Y, Takekawa K, Fujioka Y, Fujisawa T, Nakagawa Y, Hamada Y, Shibata M, Ogihara T 1995 The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38:503-508
42. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP 1995 Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes and yellow fur. Proc Natl Acad Sci USA 92:4728-4732
43. Stenbit AE, Tsao T-S, Burcelin R, Geenen DL, Factor SM, Houseknecht K, Katz EB, Charron MJ 1997 GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 10:1046-1101
44. Unger RH 1994 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Biochemistry 33:7460-7469